Sign Up to like & get
recommendations!
0
Published in 2018 at "Pharmaceutical Medicine"
DOI: 10.1007/s40290-018-0241-y
Abstract: The Innovative Medicines Initiative is a public–private partnership between the European Union and the pharmaceuticals industry that was established in 2008, with an overall budget of €5.3 billion from 2008 until 2024. The objective of…
read more here.
Keywords:
progress date;
initiative progress;
medicines initiative;
innovative medicines ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "European journal of cancer"
DOI: 10.1016/j.ejca.2018.09.013
Abstract: According to data from recent studies from Europe, a large percentage of patients have restricted access to innovative medicines for metastatic melanoma. Melanoma World Society and European Association of Dermato-oncology conducted a Web-based survey on…
read more here.
Keywords:
innovative medicines;
access innovative;
metastatic melanoma;
access ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Health policy"
DOI: 10.1016/j.healthpol.2018.08.009
Abstract: The German market for innovative medicines is characterized by simultaneous underuse and overuse. In order to address these deficits and improve decision making by physicians, the German parliament recently passed a law which mandates implementing…
read more here.
Keywords:
innovative medicines;
medicines germany;
justification government;
germany justification ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2023.1140722
Abstract: The European Commission's Innovative Medicines Initiative (IMI) has funded many projects focusing on neurodegenerative disorders (ND) that aimed to improve the diagnosis, prevention, treatment and understanding of NDs. To facilitate collaboration across this project portfolio,…
read more here.
Keywords:
impact analysis;
impact;
neuronet project;
project ... See more keywords